REVOLUTIONIZING PRECISION MEDICINE FOR PATIENTS. BY PATIENTS.

We are a team of scientists, biotech professionals, and parents making medicines for suffering and dying children with genetic diseases.

We know most of the 200m children with a rare genetic disease will never see a treatment due to the current healthcare model.

We have discovered genetic technologies that can treat many of these diseases, and a business model that will bring treatments to many of these patients.

CHRYSALIS GENETICS is a new precision medicine model for genetic treatments.

We stand on the shoulders of giants like patient families, and healthcare innovators like Henri Termeer.

We are born from the incredible stories of precision medicine for children, like Rose McPherson.

We exist for patients. To bring them genetic treatments at unprecedented speed and scale. Starting with our most precious resource, our children.

Rose - a child with a mutation in the HNRNPH2 gene

Rare disease is not rare. Treatments are.

250+ new rare diseases discovered every year.

less than 50 new rare treatments approved every year.

10k rare genetic diseases. 200m children suffer from them. 5% have treatments.

30% of those children die before their 5th birthday.

This is unacceptable.

If we have the technology to cure many of these diseases....we must build the systems to do it at scale.

Patients are waiting.